Elkhorn Partners’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
Other funds holding NEPH
Elkhorn Partners's NEPH Position: Q3 2026 in Review
Elkhorn Partners held its Nephros (NEPH) position steady in Q3 2026 at 11,000 shares worth $40.8K. The position accounts for 0.04% of the portfolio, ranked #38.
Elkhorn Partners first reported a position in NEPH in Q4 2019 and has held it in 28 quarters since. The position peaked at $123K in Q4 2020. 36 funds tracked by Wall St. Rank hold NEPH as of Q3 2026.
- Elkhorn Partners held 11,000 shares of Nephros worth $40.8K as of Q3 2026.
- Elkhorn Partners left its Nephros share count unchanged in Q3 2026.
- Nephros made up 0.04% of Elkhorn Partners's portfolio in Q3 2026, its #38 holding.
- Elkhorn Partners first reported a position in Nephros in Q4 2019 and has held it in 28 quarters since.
- Elkhorn Partners's Nephros position peaked at $123K in Q4 2020.
- 36 funds tracked by Wall St. Rank held Nephros as of Q3 2026.
Based on Elkhorn Partners's 13F filing for Q3 2026, filed 13 Nov 2026.